[TVTX] YoY Quarter Result on 30-Jun-2023 [#Q2]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
03-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 0.81%
YoY- -27.74%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 54,116 59,697 54,167 54,617 48,430 44,707 41,337 4.58%
PBT -69,567 -85,565 -66,979 -38,963 -26,003 -38,632 -22,162 20.98%
Tax 85 65 53 49 65 69 167 -10.63%
NP -70,409 -85,630 -67,032 -39,012 -26,068 -38,701 -22,329 21.07%
Tax Rate - - - - - - - -
Total Cost 124,525 145,327 121,199 93,629 74,498 83,408 63,666 11.81%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -130.11 -143.44 -123.75 -71.43 -53.83 -86.57 -54.02 15.76%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.91 -1.13 -1.05 -0.64 -0.58 -0.92 -0.56 8.42%
EPS Diluted -0.91 -1.13 -1.05 -0.64 -0.58 -0.92 -0.56 8.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.